RadNet Price to Sales Ratio 2012-2026 | RDNT
Historical PS ratio values for RadNet (RDNT) over the last 10 years. The current P/S ratio for RadNet as of June 15, 2026 is .
| RadNet P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-15 | 57.05 | 2.03 | |
| 2026-03-31 | 55.89 | $28.11 | 1.99 |
| 2025-12-31 | 71.35 | $26.97 | 2.65 |
| 2025-09-30 | 76.21 | $26.07 | 2.92 |
| 2025-06-30 | 56.91 | $25.45 | 2.24 |
| 2025-03-31 | 49.72 | $25.12 | 1.98 |
| 2024-12-31 | 69.84 | $25.01 | 2.79 |
| 2024-09-30 | 69.39 | $25.13 | 2.76 |
| 2024-06-30 | 58.92 | $24.83 | 2.37 |
| 2024-03-31 | 48.66 | $25.20 | 1.93 |
| 2023-12-31 | 34.77 | $25.74 | 1.35 |
| 2023-09-30 | 28.19 | $25.93 | 1.09 |
| 2023-06-30 | 32.62 | $26.16 | 1.25 |
| 2023-03-31 | 25.03 | $25.76 | 0.97 |
| 2022-12-31 | 18.83 | $25.05 | 0.75 |
| 2022-09-30 | 20.35 | $24.59 | 0.83 |
| 2022-06-30 | 17.28 | $24.70 | 0.70 |
| 2022-03-31 | 22.37 | $24.77 | 0.90 |
| 2021-12-31 | 30.11 | $24.67 | 1.22 |
| 2021-09-30 | 29.31 | $24.49 | 1.20 |
| 2021-06-30 | 33.69 | $23.92 | 1.41 |
| 2021-03-31 | 21.75 | $21.40 | 1.02 |
| 2020-12-31 | 19.57 | $21.03 | 0.93 |
| 2020-09-30 | 15.35 | $20.96 | 0.73 |
| 2020-06-30 | 15.87 | $21.16 | 0.75 |
| 2020-03-31 | 10.51 | $23.16 | 0.45 |
| 2019-12-31 | 20.30 | $23.04 | 0.88 |
| 2019-09-30 | 14.36 | $22.34 | 0.64 |
| 2019-06-30 | 13.79 | $21.51 | 0.64 |
| 2019-03-31 | 12.39 | $20.78 | 0.60 |
| 2018-12-31 | 10.17 | $20.14 | 0.50 |
| 2018-09-30 | 15.05 | $19.83 | 0.76 |
| 2018-06-30 | 15.00 | $19.63 | 0.76 |
| 2018-03-31 | 14.40 | $19.47 | 0.74 |
| 2017-12-31 | 10.10 | $19.55 | 0.52 |
| 2017-09-30 | 11.55 | $19.40 | 0.60 |
| 2017-06-30 | 7.75 | $19.46 | 0.40 |
| 2017-03-31 | 5.90 | $19.25 | 0.31 |
| 2016-12-31 | 6.45 | $18.98 | 0.34 |
| 2016-09-30 | 7.40 | $18.93 | 0.39 |
| 2016-06-30 | 5.34 | $18.74 | 0.28 |
| 2016-03-31 | 4.83 | $18.65 | 0.26 |
| 2015-12-31 | 6.18 | $18.24 | 0.34 |
| 2015-09-30 | 5.55 | $17.77 | 0.31 |
| 2015-06-30 | 6.69 | $17.29 | 0.39 |
| 2015-03-31 | 8.40 | $16.86 | 0.50 |
| 2014-12-31 | 8.54 | $16.84 | 0.51 |
| 2014-09-30 | 6.62 | $17.02 | 0.39 |
| 2014-06-30 | 6.63 | $17.30 | 0.38 |
| 2014-03-31 | 2.84 | $17.60 | 0.16 |
| 2013-12-31 | 1.67 | $17.77 | 0.09 |
| 2013-09-30 | 2.41 | $17.36 | 0.14 |
| 2013-06-30 | 2.65 | $16.92 | 0.16 |
| 2013-03-31 | 2.80 | $16.68 | 0.17 |
| 2012-12-31 | 2.53 | $16.58 | 0.15 |
| 2012-09-30 | 2.78 | $16.40 | 0.17 |
| 2012-06-30 | 2.66 | $16.09 | 0.17 |
| 2012-03-31 | 3.18 | $15.60 | 0.20 |
| 2011-12-31 | 2.13 | $15.17 | 0.14 |
| 2011-09-30 | 2.44 | $14.43 | 0.17 |
| 2011-06-30 | 4.40 | $14.50 | 0.30 |
| 2011-03-31 | 3.50 | $14.55 | 0.24 |
| 2010-12-31 | 2.82 | $14.10 | 0.20 |
| 2010-09-30 | 2.40 | $14.71 | 0.16 |
| 2010-06-30 | 2.37 | $14.62 | 0.16 |
| 2010-03-31 | 3.18 | $14.51 | 0.22 |
| 2009-12-31 | 2.04 | $14.66 | 0.14 |
| 2009-09-30 | 2.59 | $14.48 | 0.18 |
| 2009-06-30 | 2.25 | $14.32 | 0.16 |
| 2009-03-31 | 1.24 | $14.22 | 0.09 |
| 2008-12-31 | 3.35 | $13.86 | 0.24 |
| 2008-09-30 | 4.01 | $13.19 | 0.30 |
| 2008-06-30 | 6.20 | $12.83 | 0.48 |
| 2008-03-31 | 7.04 | $12.17 | 0.58 |
| 2007-12-31 | 10.15 | $12.05 | 0.84 |
| 2007-09-30 | 8.90 | $7.15 | 1.24 |
| 2007-06-30 | 9.53 | $5.99 | 1.59 |
| 2007-03-31 | 5.71 | $4.98 | 1.15 |
| 2006-12-31 | 4.62 | $3.82 | 1.21 |
| 2006-10-31 | 5.14 | $7.71 | 0.67 |
| 2006-09-30 | 5.44 | $7.61 | 0.71 |
| 2006-07-31 | 3.40 | $7.64 | 0.44 |
| 2006-06-30 | 3.50 | $7.58 | 0.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |